PT1194132E - Formas de dosagem delibertacao em dois tempos, compreendendo um hipnotico ou umseu sal, de actuacao curta - Google Patents

Formas de dosagem delibertacao em dois tempos, compreendendo um hipnotico ou umseu sal, de actuacao curta

Info

Publication number
PT1194132E
PT1194132E PT00954518T PT00954518T PT1194132E PT 1194132 E PT1194132 E PT 1194132E PT 00954518 T PT00954518 T PT 00954518T PT 00954518 T PT00954518 T PT 00954518T PT 1194132 E PT1194132 E PT 1194132E
Authority
PT
Portugal
Prior art keywords
umseu
comprehending
deliberation
hypnotic
sal
Prior art date
Application number
PT00954518T
Other languages
English (en)
Inventor
Gareth Lewis
Gerard Alaux
Frederic Andre
Jean Ducassou
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8242028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1194132(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PT1194132E publication Critical patent/PT1194132E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
PT00954518T 1999-06-28 2000-06-27 Formas de dosagem delibertacao em dois tempos, compreendendo um hipnotico ou umseu sal, de actuacao curta PT1194132E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401605A EP1064937A1 (en) 1999-06-28 1999-06-28 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
PCT/EP2000/006792 WO2001000181A2 (en) 1999-06-28 2000-06-27 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Publications (1)

Publication Number Publication Date
PT1194132E true PT1194132E (pt) 2004-10-29

Family

ID=8242028

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00954518T PT1194132E (pt) 1999-06-28 2000-06-27 Formas de dosagem delibertacao em dois tempos, compreendendo um hipnotico ou umseu sal, de actuacao curta

Country Status (28)

Country Link
EP (2) EP1064937A1 (pt)
JP (1) JP2003503340A (pt)
KR (1) KR20020015064A (pt)
CN (1) CN100415216C (pt)
AR (1) AR024491A1 (pt)
AT (1) ATE269062T1 (pt)
AU (1) AU782162B2 (pt)
BR (1) BR0011994A (pt)
CA (1) CA2370556C (pt)
CO (1) CO5190680A1 (pt)
CZ (1) CZ20014640A3 (pt)
DE (1) DE60011617T2 (pt)
DK (1) DK1194132T3 (pt)
ES (1) ES2222223T3 (pt)
HK (1) HK1043057B (pt)
HU (1) HU227810B1 (pt)
IL (1) IL146928A0 (pt)
MX (1) MXPA01013212A (pt)
NO (1) NO20016283L (pt)
NZ (1) NZ515997A (pt)
PL (1) PL201777B1 (pt)
PT (1) PT1194132E (pt)
SI (1) SI1194132T1 (pt)
SK (1) SK285347B6 (pt)
TR (1) TR200103594T2 (pt)
TW (1) TWI285118B (pt)
WO (1) WO2001000181A2 (pt)
ZA (1) ZA200110005B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7335500A (en) * 1999-08-26 2001-03-19 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US7811557B1 (en) * 2000-10-27 2010-10-12 Viacell, Inc. Methods for improving central nervous system functioning
JP2004525955A (ja) * 2001-04-05 2004-08-26 コッラジェネックス ファーマシューチカルス インコーポレイテッド テトラサイクリン化合物およびテトラサイクリン誘導体の制御された伝達
CA2452874A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
JP4417110B2 (ja) * 2001-12-19 2010-02-17 株式会社三和化学研究所 放出制御型成型品
EP1941878A1 (en) * 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative non-benzodiazepine formulations
JP2005518406A (ja) * 2002-01-10 2005-06-23 バイオヴェイル ラボラトリーズ インコーポレイテッド 鎮静非ベンゾヂアゼピン製剤
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
EP1556024A4 (en) * 2002-10-25 2007-01-17 Collegium Pharmaceutical Inc INTERMITTENT LIBERATION COMPOSITIONS OF MILNACIPRANE
JP4681843B2 (ja) * 2004-09-30 2011-05-11 日本臓器製薬株式会社 固形医薬製剤
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
FR2887455B1 (fr) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation a liberation prolongee de principes actifs de medicaments
AU2006322314A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
AR056633A1 (es) * 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
KR20070091960A (ko) * 2006-03-08 2007-09-12 주식회사종근당 졸피뎀 또는 그의 염을 포함하는 안전한 제어방출형 제제조성물
WO2007121537A1 (en) * 2006-04-26 2007-11-01 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
AU2013202441B2 (en) * 2006-04-26 2016-02-25 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
JP5275560B2 (ja) * 2006-10-24 2013-08-28 小林化工株式会社 酒石酸ゾルピデム含有素錠の製造方法
EP1938805A1 (en) * 2006-12-22 2008-07-02 LEK Pharmaceuticals D.D. Monolithic sustained release zolpidem tablets
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
WO2009021127A2 (en) * 2007-08-07 2009-02-12 Neurogen Corporation Controlled released compositions
CN102149369B (zh) 2008-04-18 2016-08-10 因泰克制药有限公司 卡比多巴/左旋多巴胃滞留给药
US20100068283A1 (en) 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex VIVO modifiable particle or polymeric material medicament carrier
PL2378883T3 (pl) * 2008-12-04 2016-06-30 Intec Pharma Ltd SYSTEM DOSTARCZANIA LEKU ZATRZYMYWANEGO W ŻOŁĄDKU dLA ZALEPLONU
CN102470108A (zh) * 2009-07-07 2012-05-23 桑诺维恩药品公司 非pH依赖型制剂(6-(5-氯-2-吡啶基)-5-[(4-甲基-1-哌嗪基)羰氧基]-7-氧代-6，7-二氢-5H-吡咯并[3，4-b]吡嗪)
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
TWI505841B (zh) * 2011-09-29 2015-11-01 Taiwan Biotech Co Ltd 治療睡眠障礙之控釋調配物
KR101774721B1 (ko) * 2014-02-06 2017-09-04 란 보 첸 수면을 돕기 위한 조성물 및 방법
RU2659200C1 (ru) * 2017-07-24 2018-06-28 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтический состав, содержащий алимемазина тартрат

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
GB2185887B (en) * 1987-02-18 1989-12-06 Farmitalia Carlo Erba Ltd Temazepam composition
FI894611A (fi) * 1988-09-30 1990-03-31 May & Baker Ltd Granulaera farmaceutiska preparat.
FR2656303B1 (fr) * 1989-12-26 1994-06-10 Parke Davis Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof

Also Published As

Publication number Publication date
SK19112001A3 (sk) 2002-05-09
AR024491A1 (es) 2002-10-02
ES2222223T3 (es) 2005-02-01
PL357348A1 (en) 2004-07-26
MXPA01013212A (es) 2002-06-21
AU6694400A (en) 2001-01-31
HUP0201907A3 (en) 2004-05-28
EP1194132A2 (en) 2002-04-10
KR20020015064A (ko) 2002-02-27
CA2370556C (en) 2009-09-01
DE60011617D1 (de) 2004-07-22
WO2001000181A2 (en) 2001-01-04
PL201777B1 (pl) 2009-05-29
DE60011617T2 (de) 2005-06-09
BR0011994A (pt) 2002-03-05
NZ515997A (en) 2004-03-26
DK1194132T3 (da) 2004-10-11
ZA200110005B (en) 2003-02-26
AU782162B2 (en) 2005-07-07
CO5190680A1 (es) 2002-08-29
HK1043057A1 (en) 2002-09-06
EP1064937A1 (en) 2001-01-03
HUP0201907A2 (hu) 2002-12-28
WO2001000181A3 (en) 2001-03-01
TWI285118B (en) 2007-08-11
CN1358087A (zh) 2002-07-10
NO20016283D0 (no) 2001-12-20
ATE269062T1 (de) 2004-07-15
CZ20014640A3 (cs) 2002-03-13
HU227810B1 (en) 2012-03-28
NO20016283L (no) 2002-02-27
TR200103594T2 (tr) 2002-06-21
JP2003503340A (ja) 2003-01-28
SK285347B6 (sk) 2006-11-03
HK1043057B (zh) 2005-02-25
CN100415216C (zh) 2008-09-03
SI1194132T1 (en) 2004-10-31
CA2370556A1 (en) 2001-01-04
IL146928A0 (en) 2002-08-14
EP1194132B1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
PT1194132E (pt) Formas de dosagem delibertacao em dois tempos, compreendendo um hipnotico ou umseu sal, de actuacao curta
NO20032733D0 (no) Difenyl azetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO20032735D0 (no) Difenyl azetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NL300349I1 (nl) Digesubstitueerde bicyclische heterocyclische verbindingen, de bereidingen en het gebruik ervan als geneesmiddel
NO20034931L (no) Substituerte 2-pyridin-cykloheksan-1,4-diaminderivater
NO20030870L (no) Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav
DE60111734D1 (de) [1,4']-bipiperidin verbindungen
FR2750780B1 (fr) Compteur de doses
PT1427711E (pt) Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos
ID28428A (id) Benda kesehatan penyerap sekali pakai
DE60109554D1 (de) Tragender Wegwerfartikel
DK0918501T3 (da) Tamponindføringsindretning med åbninger til fingergreb
BR0103754B1 (pt) artigo descartÁvel.
PT1253932E (pt) Composicoes farmaceuticas de toxina botulinica
BR0101471B1 (pt) aplicador dental descartável.
DE60139220D1 (de) Verstellbare Spindelverriegelung
AR016828A1 (es) Articulo descartable
DE60141934D1 (de) Harzbeschichtete nahtlose Dose
DE60315457D1 (de) Hautreinigungsmittel enthaltend kationische verbindungen
BR0105212B1 (pt) artigo descartável do vestuário.
NO308580B1 (no) Anvendelse av kondenserte cykliske forbindelser for fremstilling av en antihypertriglyceridemisk medisin
DE29905172U1 (de) Handprogrammer
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
BR9901609B1 (pt) artigo absorvente descartável de fluidos corporais.
AU6749201A (en) Use of stilbene derivatives for dandruff treatment